| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.633 | 2.002 | 1.007 | 0 | 0 | 45 | 2.347 | 1.076 | 0 | 0 |
| Total Income - EUR | 4.633 | 2.003 | 1.007 | 0 | 0 | 45 | 2.347 | 1.076 | 0 | 0 |
| Total Expenses - EUR | 4.559 | 1.905 | 920 | 0 | 577 | 1.719 | 536 | 84 | 0 | 0 |
| Gross Profit/Loss - EUR | 74 | 98 | 87 | 0 | -577 | -1.674 | 1.811 | 992 | 0 | 0 |
| Net Profit/Loss - EUR | -65 | 37 | 56 | 0 | -577 | -1.675 | 1.739 | 960 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Deniro Petymed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.860 | 1.765 | 1.763 | 1.731 | 1.121 | 17 | 1.181 | 2.151 | 2.144 | 2.132 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1.860 | 1.765 | 1.763 | 1.731 | 1.121 | 17 | 1.181 | 2.151 | 2.144 | 2.132 |
| Shareholders Funds | 1.668 | 1.688 | 1.716 | 1.685 | 1.076 | -620 | 1.133 | 2.097 | 2.090 | 2.079 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 192 | 77 | 47 | 46 | 45 | 637 | 48 | 54 | 54 | 54 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Deniro Petymed S.r.l.